Clinical Trials Browser

Phase 4 × OTHER × ledipasvir, sofosbuvir drug combination × Clear all

NCT02717949 2019-01-08

Optimal

Phase 4 Terminated

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin